PARP1 and acute myeloid leukemia: In conclusion, in the present study, we demonstrated that PARP-1 is highly expressed in AML patients′ cells and K562 and THP1 cells, and that the inhibitor Olaparib exerts a chemosensitization effect when combined with IDA.